Significant change in ZAP‐70 expression during the course of chronic lymphocytic leukemia
暂无分享,去创建一个
J. Krejsek | F. Vrbacky | L. Smolej | J. Malý | K. Jankovičová | V. Vroblová | M. Hrudková | D. Schmitzová | F. Vrbacký
[1] J. Philippé,et al. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. , 2009, Leukemia research.
[2] S. Johnson,et al. ZAP-70 expression remains stable in chronic lymphocytic leukaemia. , 2007, International journal of laboratory hematology.
[3] F. Ajchenbaum‐Cymbalista,et al. National standardization of ZAP‐70 determination by flow cytometry: The French experience , 2007, Cytometry. Part B, Clinical cytometry.
[4] P. Morel,et al. Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia? , 2007, Leukemia & lymphoma.
[5] F. Lo Coco,et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. , 2006, Blood.
[6] N. Villamor,et al. Evaluation of ZAP‐70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process , 2006, Cytometry. Part B, Clinical cytometry.
[7] J. Roliński,et al. Comparison of methods for determining zeta‐chain associated protein – 70 (ZAP‐70) expression in patients with B‐cell chronic lymphocytic leukemia (B‐CLL) , 2006, Cytometry. Part B, Clinical cytometry.
[8] L. Klein-Hitpass,et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[9] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.
[10] Adrian Wiestner,et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.
[11] T. Möröy,et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia , 2003, Leukemia.
[12] Emili Montserrat,et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.
[13] D. Oscier,et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.
[14] David Botstein,et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.
[15] K. Do,et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. , 2001, Blood.
[16] N. Chiorazzi,et al. Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. , 2005, Current topics in microbiology and immunology.
[17] D. Catovsky,et al. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. , 2004, The hematology journal : the official journal of the European Haematology Association.
[18] J. Dürig,et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia , 2002, Leukemia.
[19] A. Weiss,et al. Molecular and genetic insights into T cell antigen receptor signal transduction. , 1994, Advances in experimental medicine and biology.